Hansa Biopharma: Supportive top-line clinical results in sequential gene therapy combination - Redeye
The combination of ELEVIDYS from Sarepta and Imlifidase records early supportive top-line data for patients resistant to ELEVIDYS when treating three Duchenne muscular dystrophy (DMD) patients.
ANNONS
The combination of ELEVIDYS from Sarepta and Imlifidase records early supportive top-line data for patients resistant to ELEVIDYS when treating three Duchenne muscular dystrophy (DMD) patients.
